Vaccine capital: Spotlight on Hyderabad; city set to produce a third of the world's dosage

Be it India ’s first indigenous Covid-19 vaccine candidate Covaxin or Russia’s Sputnik V, Johnson& Johnson ’s Ad26.Cov2.S, FluGen’s CoroFlu or even Sanofi’s under development vaccine candidates, all have a Hyderabad connect.
Source: The Economic Times - Category: Consumer Health News Source Type: news